Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 3759 3,4 2?
Displaying drugs 11451 - 11475 of 12671 in total
Experimental
Matched Iupac: … (2S)-2-acetamido-3-hydroxypropanoic acid …
Experimental
Matched Iupac: … 6-(cyclohexylmethoxy)-9H-purin-2-amine …
Experimental
Matched Iupac: … 2-[(diaminomethyl)(methyl)amino]acetic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-disulfanylpropanoic acid …
Experimental
Matched Iupac: … 2-[carboxy(hydroxy)amino]acetic acid …
Experimental
Matched Iupac: … (2S)-2-amino-4-methaneseleninylbutanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-4-hydroxybutanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-5-oxohexanoic acid …
N-chlorotaurine is an inhibitor of inducible nitric oxide synthase and IkappaB kinase.
Investigational
Matched Iupac: … 2-(chloroamino)ethane-1-sulfonic acid …
Experimental
Matched Iupac: … (2S)-2-hexanamido-4-hydroxybutanoic acid …
Experimental
Matched Iupac: … 2-(naphthalen-1-yloxy)acetic acid …
Cyclopentamine is a sympathomimetic alkylamine, classified as a vasoconstrictor. Cyclopentamine was an over the counter treatment for nasal congestion in Europe and Australia. It has been widely discontinued due to the safety, effectiveness, and availability of a similar drug, propylhexedrine.
Withdrawn
Matched Iupac: … (1-cyclopentylpropan-2-yl)(methyl)amine …
Matched Salts cas: … 538-02-3
Experimental
Matched Iupac: … (4,4-diphenylbutan-2-yl)(ethyl)dimethylazanium …
Experimental
Matched Iupac: … benzyl(dodecyl)bis(2-hydroxyethyl)azanium …
Experimental
Matched Iupac: … N-[(azocan-2-yl)methyl]guanidine …
Experimental
Matched Iupac: … aluminium(3+) 2-aminoacetate hydrate dihydroxide …
Experimental
Matched Iupac: … 3,5-dibenzyl-1,3,5-thiadiazinane-2-thione …
CXL-1020 is under investigation in clinical trial NCT01092325 (Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure).
Investigational
Matched Iupac: … N-hydroxy-2-methanesulfonylbenzene-1-sulfonamide …
Methcathinone is under investigation in clinical trial NCT02617862 (PCI Imaging System in Pediatric Ophthalmology).
Investigational
Matched Iupac: … 2-(methylamino)-1-phenylpropan-1-one …
Experimental
Matched Iupac: … (2R,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6S)-6-{[(1R,4S,5S,6R)-4-{[(2R,3S,4S,5R,6R)-6-{[(2R,3S,4R,5R,6R)-4,5 ... -dihydroxy-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-methyloxan-3-yl]oxy}oxan-3-yl]oxy ... -2-(hydroxymethyl)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol ... }-4,5-dihydroxy-2-methyloxan-3-yl]amino}-5,6-dihydroxy-2-(hydroxymethyl)cyclohex-2-en-1-yl]oxy}-4,5-dihydroxy …
Experimental
Matched Iupac: … 3-(4-carbamimidoylphenyl)-2-oxopropanoic acid …
Experimental
Matched Iupac: … (2S)-5-(carbamoylamino)-2-acetamidopentanoic acid …
Experimental
Matched Iupac: … (3S,4S)-1,3,4,5-tetrahydroxypentan-2-one …
Experimental
Matched Iupac: … (2S)-2-(carbamoylamino)-3-phenylpropanoic acid …
Palifosfamide (ZIO-201) is a proprietary stabilized metabolite of ifosfamide. Ifosfamide has been shown to be effective in high doses in treating testicular cancer, sarcoma and lymphoma.
Investigational
Matched Iupac: … bis[(2-chloroethyl)amino]phosphinic acid …
Displaying drugs 11451 - 11475 of 12671 in total